Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion
about
Lymph vessels: the forgotten second circulation in health and diseasePancreatic cancer: yesterday, today and tomorrow.Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinomaNeoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survivalThe Association between Survival and the Pathologic Features of Periampullary Tumors Varies over Time.Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.Is tumour size an underestimated feature in the current TNM system for malignancies of the pancreatic head?Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse modelsAdvanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review.A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered.Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.Perineural invasion and associated pain in pancreatic cancer.Advanced-stage pancreatic cancer: therapy options.The lymphatic system and pancreatic cancer.Reporting the margin in pancreaticoduodenectomies: R0 versus R1.Pancreaticoduodenectomy: outcomes in a low-volume, specialised Hepato Pancreato Biliary unit.Surgical management in patients with pancreatic cancer: a Queensland perspective.Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.Is it time to stop checking frozen section neck margins during pancreaticoduodenectomy?Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom.Prognostic role of the neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomComparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data
P2860
Q26750211-4BB64E35-A278-49B0-B9DA-7DA05402EE14Q30250026-6D726693-9FA0-4E0E-800B-BC29FDAEEF28Q33656076-F31ECC5D-4F76-491E-BBE5-D67C7FC825F4Q33809495-5DD1CE78-ED6C-43C3-8C8A-0FE4707AB914Q33914755-EE150001-A3AD-476A-9822-DD6CC1F60B5AQ35142799-B9825C4D-F92A-44BD-9182-BDB265B3BEF5Q35692297-2F70FE14-3BD2-4ED9-A8C3-82B0B04D1CE2Q35785646-32F6B03E-6001-4E4E-897C-DB91F8EDB006Q35848380-F326AF0A-F50C-4D56-8892-CE555F8ACF43Q35854755-7B5D31EA-6E11-49A1-BBDC-05A871F1A718Q36059059-E2B1A9D8-CC0B-498F-BBBC-1A46D1EAC361Q36288739-45E10E01-F39E-4657-A75A-7363E2DB183AQ36747404-405F3176-DCA8-4A1F-AD61-CA7DB37D7F74Q37092146-605037F1-2BD5-4055-908D-44D384539947Q37628439-82C003B5-2C70-48E5-820B-CA3743D016ECQ37937421-27963317-4476-444A-98A6-2C66DB2660E6Q38102914-0E734CF6-6A9C-4639-B57E-585F2A53ABC2Q38689578-476BB372-80D6-477D-8D28-247995BB1594Q38833318-710902C8-8452-4B34-A47B-739A9FDACC7DQ43803590-4257D733-1E48-402E-AD1A-7DF8C64DF568Q44256597-908F584D-252C-4EDF-B4B4-DF89FE2CAD46Q44621438-898C13D0-CE3A-4A77-B35D-AF639B591D4FQ45392240-84AD07DC-6153-4F72-94E6-B37070143899Q48312347-78F0CC4E-40B3-487C-9756-503FBCC93AD2Q50047446-0B4BE8F3-CADF-43C6-B3BE-36E249406FE2Q52339747-00A4C509-37F4-48F0-870B-D3323EC6D6A7Q58695712-AAEBB617-7F24-40E6-8C7A-3BFF196AA0C0
P2860
Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Predicting patient survival af ...... on and lymphovascular invasion
@ast
Predicting patient survival af ...... on and lymphovascular invasion
@en
type
label
Predicting patient survival af ...... on and lymphovascular invasion
@ast
Predicting patient survival af ...... on and lymphovascular invasion
@en
prefLabel
Predicting patient survival af ...... on and lymphovascular invasion
@ast
Predicting patient survival af ...... on and lymphovascular invasion
@en
P2093
P2860
P1476
Predicting patient survival af ...... on and lymphovascular invasion
@en
P2093
David S Astill
James Toouli
John W C Chen
Lilian Kow
Mark Brooke-Smith
Mayank Bhandari
Robert T A Padbury
Thomas G Wilson
P2860
P304
P356
10.1111/J.1477-2574.2009.00140.X
P577
2010-03-01T00:00:00Z